Urologix, Inc. (ULGX) Reports Q4 Loss of $0.08

Urologix, Inc. (NASDAQ: ULGX) reported Q4 EPS of ($0.08), versus ($0.05) reported last year. Revenue for the quarter came in at $4.65 million, versus $3.32 million reported last year.

For earnings history and earnings-related data on Urologix, Inc. (ULGX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
• UBS Reiterates Neutral Rating on Oxford Industries (OXM)
• Williams-Sonoma (WSM) Tops Q2 EPS by 4c